PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 4, 2015
Insider Transaction Report
Form 4
Lovallo Angelo William JR
Vice President Finance
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2015-03-02$6.65/sh+52,800$351,120→ 52,800 totalExercise: $6.65Exp: 2025-03-02→ Common Stock (52,800 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.